Also written by Chen L , Et Al.:
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2.
x hide permanently

Characterisation of the p53 pathway in cell lines established from TH-MYCN transgenic mouse tumours.

ncbi.nlm.nih.gov

Characterisation of the p53 pathway in cell lines established from TH-MYCN transgenic mouse tumours.

Int J Oncol. 2018 Jan 31;:

Authors: Chen L, Esfandiari A, Reaves W, Vu A, Hogarty MD, Lunec J, Tweddle DA

Abstract Cell lines established from the TH-MYCN transgenic murine model of neuroblastoma are a valuable preclinical, immunocompetent, syngeneic model of neuroblastoma, for which knowledge of their p53 pathway status is important.

Mentions: MYCN